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The EUROCarbDB project is a design study for a technical
framework, which provides sophisticated, freely accessible,
open-source informatics tools and databases to support
glycobiology and glycomic research. EUROCarbDB is a
relational database containing glycan structures, their
biological context and, when available, primary and
interpreted analytical data from high-performance liquid
chromatography, mass spectrometry and nuclear magnetic
resonance experiments. Database content can be accessed
via a web-based user interface. The database is complemen-
ted by a suite of glycoinformatics tools, speciﬁcally designed
to assist the elucidation and submission of glycan structure
and experimental data when used in conjunction with con-
temporary carbohydrate research workﬂows. All software
tools and source code are licensed under the terms of the
Lesser General Public License, and publicly contributed
structures and data are freely accessible. The public test
version of the web interface to the EUROCarbDB can be
found at http://www.ebi.ac.uk/eurocarb.
Keywords: databases / glycoinformatics /informatics tools /
open-source
Introduction
The inherent complexity of glycan structures and the microhe-
terogeneity in naturally occurring glycans make analysis of
glycoconjugates very challenging. A complete and detailed
characterization of glycan structures is a time-consuming
analytical process that typically requires a complex approach
for detecting small quantities of glycans on low-abundance gly-
coproteins. It is widely accepted that glycosylation is the most
complex and prevalent post-translational modiﬁcation, which is
important for protein folding, stability and function, with
implications in signal transduction, differentiation, immunity,
inﬂammation, cancer and other disease progressions (Rudd
et al. 2001; Morelle and Michalski 2007; Arnold et al. 2008;
Marth and Grewal 2008; Zaia 2008; An et al. 2009; Dennis
et al. 2009; Taniguchi et al. 2009; Tharmalingam et al. 2010).
Our understanding of glycan function is rapidly expanding
through our improved understanding of the molecular glycosy-
lation machinery and with advances in high-throughput
glycomic strategies and glycoinformatics.
Over the past decade, there has been rapid progress in the
development and availability of glycoanalytical technologies
(Morelle and Michalski 2007; Widmalm 2007; Royle et al.
2008; Zaia 2008; Bielik and Zaia 2009; Blow 2009; North
et al. 2009; Tharmalingam et al. 2010; Vanderschaeghe et al.
2010). These technical innovations and the increasing
amounts of data generated by high-throughput techniques
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493allow for the rapid structural analysis of complex glycans.
The complexity and volume of data routinely generated now
necessitate bioinformatic solutions in the form of databases
and analytical tools, either web-based or standalone, to
support data interpretation and data storage (von der Lieth
et al. 2004, 2006; Frank and Schloissnig 2010). Thus, new
ideas are required for the development of universally accepted
mechanisms and standards for storing both structural and
experimental data and for improved data annotation and disse-
mination of the conclusions drawn from such experiments.
In contrast to the genomics and proteomics ﬁelds, the gly-
cosciences lack accessible, curated and comprehensive data
collections that summarize the structure, characteristics, bio-
logical origin and potential function of glycans which have
been experimentally veriﬁed and reported in the literature.
Over the past two decades, efforts in the development of
bioinformatic resources have increased, including projects by
international consortia (Table I in Frank and Schloissnig
2010) to develop databases that support the growing require-
ment for storing and presenting data to address the needs of
the glycobiology community.
A majority of these databases have been derived, in part,
from the ﬁrst international effort to set up a carbohydrate data-
base, the Complex Carbohydrate Structure Database (CCSD),
commonly referred to as CarbBank, which was developed by
the Complex Carbohydrate Research Center (Doubet et al.
1989; Doubet and Albersheim 1992). The project started in
the late 1980s but ceased in 1997 due to lack of funding
support. The ﬁnal database contained 50,000 records com-
prising 23,000 unique sequences in the CarbBank notation
with associated biological background, chemical data and
publication information. This data set has been used by recent
initiatives to seed new databases with a basic set of glycan
structure records.
Three prominent initiatives are the Kyoto Encyclopedia of
Genes and Genomes (KEGG) Glycan (Aoki et al. 2004;
Hashimoto et al. 2006), the US consortium for functional
glycomics (CFG; Raman et al. 2006) and the
GLYCOSCIENCES.de portal (Lütteke et al. 2006). Brieﬂy,
KEGG Glycan is an integrated knowledge base of protein net-
works with genomic and chemical information and provides
access to sugar structures through the manually drawn
pathway maps representing the current knowledge of glycan
biosynthesis and metabolism for various species. The CFG
databases have been designed to host and integrate experi-
mental data produced by the various core groups of the
consortium. The GLYCOSCIENCES.de portal is a resource
for linking glycan-related data originating from various
resources through a unique structure description. Special
emphasis has been made to provide easy access to the avail-
able experimentally determined spatial structures of glycans
and to analyze their interactions with proteins. The CFG and
GLYCOSCIENCES.de databases contain collections of
experimental data from mass spectrometry (MS) proﬁles and
nuclear magnetic resonance (NMR) experiments.
Although many carbohydrate databases have been
implemented (Cooper et al. 2001, 2003; Campbell et al. 2008),
the desirable features for structure-based cross-linking and
automated exchange of data between established resources are
lacking. This weakness arises from the use of different
database-speciﬁc structure encoding formats that are difﬁcult or
impossible to cross-translate in a facile manner due to semantic
and syntactic nuances that are intractable to automatic trans-
lation (Doubet and Albersheim 1992; Bohne-Lang et al. 2001;
Aoki et al. 2004; Kikuchi et al. 2005; Campbell et al. 2008).
Thus, we are faced with a variety of incomplete databases
characterized by disconnected and incompatible collections of
experimental and structural data. This situation not only
hinders the development of bioinformatic tools but also the
realization of platforms for large-scale glycomics and glycopro-
teomics studies. As glycan-related databases improve in cover-
age and quality, it is of growing interest to consider criteria and
solutions that maximize the value that can be extracted. Recent
reviews highlight the approaches and difﬁculties the glycoinfor-
matics community is facing and those steps being taken to
create well-curated and annotated databases and efﬁcient tools
(Aoki-Kinoshita 2008; Packer et al. 2008).
Here, we present EUROCarbDB (http://www.eurocarbdb.
org), an Infrastructure Design Study funded under the sixth
EU framework program, to establish the technical require-
ments for developing a centralized and standardized database
architecture for carbohydrate-related data (structure and
analytical data). The study focused on the evaluation and
development of a robust infrastructure that supports the estab-
lished analytical methods. The initial implementation of the
EUROCarbDB outlined here includes workﬂows and tools
developed speciﬁcally for the key analytical techniques of
high-performance liquid chromatography (HPLC), MS and
NMR spectroscopy. The platform offers the following fea-
tures: (i) an introduction and/or recommendation of formats
and nomenclatures for encoding carbohydrate structures;
(ii) relational database schemas for storing curated structural
and experimental data together with a web-based user inter-
face designed to populate and curate that data; (iii) various
web-based tools for visualizing and querying all stored infor-
mation and (iv) bioinformatics research tools designed to
expedite aspects of glycan analysis and structural elucidation.
Lastly, software libraries and bioinformatics tools produced by
the project are available at http://eurocarb.googlecode.com,
under the terms of the Lesser General Public License (http://
www.gnu.org/licenses/lgpl.html).
Results and discussion
The design goals and concepts of the EUROCarbDB are far-
reaching and by no means limited to the resources presented
here. A speciﬁc design objective of the architecture of the
database was to allow for the extension and incorporation of
new modules and tools to support further types of experimen-
tal data and workﬂows. In this fashion, the emphasis through-
out the project has been to develop a comprehensive
framework that promotes accessibility and longevity through a
modular design approach and by adopting an open-source
philosophy. It is our hope that this will in turn drive the con-
tinued growth and promotion of uniﬁed glycoinformatic tools
analogous to those that have facilitated the rapid uptake of
proteomics and genomics and will allow future integration
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494with other complementary database resources such as the
PDBe: Protein Data Bank in Europe (Velankar et al. 2010).
Glycan structure encoding
A review of current and discontinued database projects ident-
iﬁed that a major issue in the design of a robust and future-
oriented data resource is the availability of an infrastructure
which can conveniently handle structural data at both the
internal database and user levels. The main goal of these
developments was to simplify the manual input of structures
while providing the capabilities for encoding all structural
characteristics of a glycan sequence in a unique and
computer-readable form. Note that throughout this report the
term “structure” will be used to refer to the more or less
detailed constitution, sequence (linkage) and stereochemistry
information available for a particular glycan and will gener-
ally not be used to denote a particular 3D spatial structure
(atomic coordinates) in the molecular modeling sense.
To motivate scientists to use newly designed resources, we
developed a rapid and intuitive glycan structure editor (see
the GlycanBuilder section) that is embedded with a controlled
set of precise monosaccharide descriptions (see the
MonosaccharideDB section) for the rapid generation of
glycan structures. The analysis of existing structures and
formats indicated that a new, more comprehensive format
(Table I) was required for the accurate encoding of structural
details in a form that can be read by the human user, as well
as by computer algorithms, and can serve as a unique identi-
ﬁer for database entries.
GlycoCT. The analysis of previous encoding formats (Table I)
showed that none of them is capable of dealing with the full
complexity to be expected for experimentally derived
carbohydrate sequence data. Therefore, we developed a new
encoding scheme for complex carbohydrates, named GlycoCT
(Herget et al. 2008).
This format utilizes a connection table (CT) approach,
instead of a linear encoding scheme, and features a controlled
vocabulary for monosaccharide building blocks and substitu-
ents, according to the IUPAC nomenclature. GlycoCT uses a
block concept to describe residues, linkages and frequently
occurring special features, such as repeating units. The
implementation of sorting rules and the ability to encode
ambiguous or only partially deﬁned structures (e.g. uncertain
terminal residue positions) as well as fully resolved structures
assures the uniqueness of the GlycoCT signature for each
given structure. It exists in two variants, a condensed form
and a more verbose XML syntax, which are described in
detail elsewhere (Herget et al. 2008) and http://www.
eurocarbdb.org/recommendations/encoding. The main intent
of GlycoCT is to be used as a unique encoding of a glycan
structure that may be readily translated to other existing text
formats and graphical representations, such as Oxford
University format, CFG notation and IUPAC text format.
Structure translation. As a seed for initial database
development, 50,000 entries were imported from the public
CarbBank repository to EUROCarbDB via an internally
developed routine. After removal of any aglyca (e.g. amino
acids or lipids, which are part of the sequence in CarbBank),
the remaining carbohydrate moiety was exported into the
GlycoCT sequence format and subsequently stored in
EUROCarbDB.
GlycanBuilder. Given the nonlinear and frequently complex
nature of carbohydrate sequences, many researchers prefer to
visualize glycans graphically, rather than as textual sequence
strings. The GlycanBuilder is an embeddable software tool
(Java applet), which can be used to visually compose glycan
structures from a set of monosaccharide building blocks
(Ceroni et al. 2007; http://www.glycoworkbench.org/wiki/
GlycanBuilder). The “view” menu of the GlycanBuilder tool
allows sequences to be generated and viewed in any of the ﬁve
graphical display schemes illustrated in Figure 1.T h eu s e rc a n
rapidly specify a glycan structure by simply selecting
successive residues and their points of attachment. The
growing structure is displayed using one of the selectable
symbolic notations. The list of structural constituents comprises
an exhaustive collection of saccharides, substituents,
reducing-end markers and saccharide modiﬁcations. All of the
stereochemical information about a saccharide, e.g. anomeric
conﬁguration, chirality, ring conﬁguration and linkage
p o s i t i o n s ,c a nb es p e c i ﬁed. The GlycanBuilder is used in the
Table I. Comparison of carbohydrate structure encoding formats in terms of structural features, which can be encoded in an unrestricted manner (+), restricted
manner (o) or not at all (–).
GlycoCT KCF LINUCS CarbBank
format
BCSDB
format
GlycoBase
(Dublin)
Linear
Code®
CabosML Glycosuite
format
Encodable features
Unknown linkage positions + + + + + + + − +
Repeat units + + + + 0 − ++ +
Cyclic sugars + − ++ −− ++ −
Undeterminded terminal
residues
+ −− + − ++ − 0
Alternative residues + −− − + − + − +
Nonstoichometric
modifications
+ −− ++ −− − 0
Compositions + + −− − − − − −
Unique sequences + − 0 − ++ + − +
Multiple connections + + −− + −− − −
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495web interface of the EUROCarbDB as the standard input
facility for structures in all contribute, browse and search
pages. Furthermore, the GlycanBuilder is embedded into the
GlycoWorkbench software (Ceroni et al. 2008) as a component
for drawing structure candidates in the process of annotating
MS spectra (see the Software tools section below). Herein,
sequences can be exported in GlycoCT as an XML ﬁle or in
any of several standard text or graphical formats. Finally,
following the open-source character of the EUROCarbDB
project, the GlycanBuilder was used in other database projects
(see http://www.glycome-db.org) as a structure input facility for
search functions (Ranzinger et al. 2008, 2009).
MonosaccharideDB. A major problem with previous
carbohydrate databases has been the frequent use of
nonuniform residue names (aliases or synonyms) for a given
monosaccharide, e.g. Fuc/6-deoxy-Gal or 2-deoxy-Glc/
2-deoxy-Man/2-deoxy-araHex. This problem can be solved by
using a controlled vocabulary of unique monosaccharide
names. In view of the large number of known monosaccharides
and the even larger number theoretically feasible, it is
impractical to adequately deﬁne a static dictionary with all
possible monosaccharides and synonyms. Therefore, in
EUROCarbDB, the dynamic, self-extensible dictionary and
routines of MonosaccharideDB are implemented to ensure
residue name consistency. The dictionary can also be accessed
independently at http://www.monosaccharidedb.org.
In addition to its own internal format (closely related to
GlycoCT), MonosaccharideDB currently supports six different
notation schemes for carbohydrates: GlycoCT (Herget et al.
2008); the LinearCode® used by the CFG (Raman et al.
2006) and Glycominds Ltd.; the LINUCS notation
(Bohne-Lang et al. 2001) used in GLYCOSCIENCES.de
(Lütteke et al. 2006); the schemes of the CCSD (Doubet et al.
1989; the extended IUPAC notation of CarbBank); the Protein
Data Bank (PDB) (Henrick et al. 2008); and the Bacterial
Carbohydrate Structure Database (BCSDB; Toukach and
Knirel 2005). To ensure unambiguous encoding of glycans,
MonosaccharideDB is capable of translating carbohydrate
residue names from different encoding schema into a unique
notation and vice versa.
EUROCarbDB database
The central aim of the EUROCarbDB design study was to
develop a comprehensive, relational database of experimen-
tally determined carbohydrate structures, supported by bio-
logical context information, literature references and empirical
structural evidence. For the purpose of the initial design
study, MS, HPLC and NMR data were designed by the
EUROCarbDB. The interaction of these database sections is
summarized in Figure 2. Here, we outline the central glycan
structure domain as well as the three evidence domains (and
the experimental features they support). Technical details will
be described in subsequent publications.
Core database. The purpose of the core database is to act as a
central resource of glycan structures, associated biological
contexts and references. Glycan structures are considered to
be the focal point of the core database and they are used to
connect the evidence domains to the core domain (Figure 2).
The initial version of the EUROCarbDB was seeded with
glycan structures as described in the Structure translation
section. Additional structures and data have also been
incorporated by EUROCarbDB partners, for example, from
the GlycoBase database (Campbell et al. 2008). Each
structure entry in EUROCarbDB is encoded in the database in
GlycoCT format as described previously.
The association of structure to biological source is captured
by the shared biological context module. A biological context
Fig. 1. Carbohydrate representations used in GlycanBuilder. Users can select from ﬁve graphical display schemes for glycan structures. As an example structure a
complex N-glycan is shown in the IUPAC Text mode, the CFG symbolic format with linkage labels, the CFGL format with linkage positions shown
geometrically and the Oxford black & white (UOXF) and color (UFOXCOL) schemes, where linkage positions are shown by geometry and anomeric
conﬁgurations are denoted by dashed (α) or solid (β) lines. Note that this structure is indeﬁnite since the linkage positions of the terminal GalNAc residues are
not deﬁned.
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speciﬁc taxonomy and tissue, together with a varying number
of disease and perturbation associations. EUROCarbDB
exclusively uses controlled vocabularies derived from and
linked directly to the public domain ontologies of NCBI
Taxonomy (Sayers et al. 2009), and the MeSH categories A,
C and D (“Anatomy”, “Diseases” and “Chemicals and Drugs”
respectively; Lowe and Barnett 1994). These controlled voca-
bularies are also innately hierarchical, such that a structure
linked to “Homo sapiens”, “Hepatocytes” and “Hepatic
cellular carcinoma” is hierarchically related to and therefore
searchable by reference to the more general nodes for
“Mammalia”, “Liver” and “Neoplasms”.
EUROCarbDB can store references for both glycan struc-
tures and experimental evidence in the form of PubMed IDs,
external database identiﬁers and other internet resources. The
current EUROCarbDB policy for submission of a unique
glycan sequence requires that at least one published literature
reference be supplied which describes the structure elucidation
process, a link to an external database or that experimental
evidence be submitted.
The ability to associate any structure entry with correspond-
ing properties or features results in a fully annotated database
of sequence information and metadata collections, which in
turn provides the technical basis for sophisticated querying
the database via the user interface.
Experimental evidence. A key design objective of the
EUROCarbDB was the creation of a database infrastructure
which supports the deposition, analysis, annotation and
curation of experimental data from the analytical techniques
of HPLC, MS and NMR—the most popular techniques for
the structure elucidation of carbohydrates. The experimental
data section of EUROCarbDB currently supports the input
(archival) of raw data, and the interpretation of these data can
provide the experimental evidence for one or more
carbohydrate structures in a given biological context.
However, EUROCarbDB can also accept new structures for
which the evidence (raw or interpreted data) is no longer
available. In this case, at least one published article in a
peer-reviewed journal or the link to an external database entry
must be provided.
High-performance liquid chromatography. One major aim of
the EUROCarbDB design study was to develop and provide a
framework for algorithms and tools to facilitate the deposition
and interpretation of HPLC data. Here, an innovative
glycoinformatic suite of well-curated databases and analytical
tools has been developed to support the growing demand for
HPLC data processing resources, such as GlycoBase and
auto-glucose unit (GU; Campbell et al. 2008). These tools are
complemented by a series of data entry and processing
workﬂows supported by a robust database framework with
interfaces for retrieving structural and experimental data.
The data model is composed of one experimental evidence
section and one metadata section—allowing for the complete
description of an HPLC experiment. The experimental evi-
dence section is used to associate glycan sequences (stored
within the central EUROCarbDB sequence database) with
their HPLC elution positions (normalized retention times,
expressed as GU values). The metadata section allows for
the storage of the following information: instrument type,
chromatographic conditions and data processing. In addition,
the associated biological context metadata can be stored for
each HPLC experiment—using the previously deﬁned facili-
ties of the core component of the EUROCarbDB.
Mass spectrometry. Is a widely used experimental technique
for the elucidation of glycan structures, either as found
attached to speciﬁc entities or within complex samples
(Harvey 1999, 2006, 2008). Therefore, an extensive collection
of tools and databases has been created.
The MS data model and interface are completely integrated
within the facilities of the EUROCarbDB core database and
were designed to provide comprehensive workﬂows from the
acquisition of raw MS data to the ﬁnal deposition of data into
Fig. 2. Architecture of EUROCarbDB. The core database contains the four components structure, biological context, (experimental) evidence and references.
Biological context comprises several categories (blue) which utilize the controlled vocabularies obtained from external databases (NCBI, MeSH). References
(green) are also obtained from external databases such as PubMed. A key feature of EUROCarbDB is the internal storage of experimental evidence (right) for a
glycan sequence.
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497the database (Figure 3). In combination with the tools,
described in the software tools section, the workﬂows allow
experimentalists to cascade all steps of structure identiﬁcation.
Starting with the generation of peak lists (using existing MS
software), the new tool called Glyco-Peakﬁnder is used to cal-
culate monosaccharide compositions from which structure can-
didates are generated. The GlycoWorkbench tool is then used
to match the peak lists with the structure candidates—produ-
cing fully annotated spectra. Finally, the web interface of the
EUROCarbDB (discussed subsequently) is used to upload the
results into the MS evidence domain, which has been designed
to store raw spectra, their subsequent annotations and the meta-
data required to fully describe each experiment, including bio-
logical context, experimental conditions and other parameters.
Nuclear magnetic resonance. The inherent volume and
complexity of the raw and interpreted NMR data generated for
glycan structure elucidation requires a sophisticated data model.
After the evaluation of various alternatives, it was decided to
use the CCPN data model (Collaborative Computing Project
for NMR, http://www.ccpn.ac.uk/index.html), for storing NMR
evidence in EUROCarbDB (Vranken et al. 2005). At the
moment only complete CCPN projects can be submitted to the
database, but the manual input of experimental data and
assignments would be easy to implement.
The EUROCarbDB web portal (www.ebi.ac.uk/eurocarb). The
web-based user interface of the EUROCarbDB allows for
searching and browsing deposited information as well as for
submitting new structures and experimental data to the
database. Users can browse the database by various aspects of
structure, experimental evidence, taxonomy, tissue, disease
and perturbation. Each glycan structure has an individual
“entry” page (Figure 4) that can be accessed either by its
EUROCarbDB identiﬁer or via links from browsing and
querying pages.
Glycan structures may be queried by a variety of structural,
reference and biological context criteria. Queries may also be
cascaded, in which results from previous queries may be nar-
rowed further by a subsequent query. EUROCarbDB also per-
forms substructure queries entirely within the database via a
novel algorithm, which allows for very fast searches.
Users initiate queries of the database using the top naviga-
tion bar that provides links for: browse, search, contribute and
tools. Below the navigation bar is the main content area that
is used for, query input and result set display. Panels on the
right-hand side of the interface allows for XML export and
the selection of glycan structure visual representation. This
component displays links to other databases and components
of the EUROCarbDB that are related to the currently dis-
played information. For example, the results of an automatic
substructure search are displayed on this component when a
glycan information page is being viewed.
For the upload of structures and data to the EUROCarbDB,
contributors are guided through a sequence of input pages.
Beginning with drawing the glycan structure, followed by
selecting the biological context, entering the reference data
and, ﬁnally, uploading spectra and/or chromatograms in a
step-by-step fashion. The GlycanBuilder tool is also used
extensively throughout the user interface as an input mechan-
ism wherever structural inputs are required.
Software tools
From the beginning, it was obvious that the development of
tools for semi-automatic interpretation of MS spectra, NMR
data or HPLC proﬁles was fundamental to the aims of the
project. Therefore, the software tools Glyco-Peakﬁnder and
GlycoWorkbench for the interpretation of MS data, autoGU for
HPLC analysis and ProSpectND and CASPER (Computer-
Assisted SPectrum Evaluation of Regular polysaccharides) for
NMR analysis were produced. Figure 5 displays the relation-
ships that exist between these tools and the EUROCarbDB.
Fig. 3. Proposed experimental workﬂow for uploading MS data into EUROCarbDB. Starting from acquired raw data, the subsequent use of MS vendor’s
software (top row) and the newly developed tools Glyco-Peakﬁnder (middle row) and GlycoWorkbench (bottom row) allows the user to perform structure
determination, peak assignments and annotation and data submission to EUROCarbDB.
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8080/database/show_glycobase.action) is an evidence
database containing the normalized HPLC elution positions
for 2-aminobenzamide-labelled glycan structures. A
standalone release of the database was described previously
(Campbell et al. 2008), which has now been extended and
fully integrated within the EUROCarbDB framework. Brieﬂy,
GlycoBase contains GU values for deﬁned glycans obtained
from a variety of sources. The information concerning
biological source, exoglycosidase digestions (enzymes used,
glycan products) and supporting publications is available
through the EUROCarbDB core database model. All
structures were determined by a combination of normal-phase
HPLC with exoglycosidase sequencing and/or were conﬁrmed
by MS, e.g. MALDI-MS, ESI-MS, ESI-MS/MS, LC-ESI-MS
and LC-ESI-MS/MS.
An intuitive workﬂow allows users to upload a series of
retention values and percentage areas from propriety HPLC
software. When combined with exoglycosidase information
using a simple step-by-step workﬂow a GlycoBase search (all
data or a speciﬁed subset) can be performed. Initial putative
structure assignments for the undigested retention list are pro-
gressively analyzed and subsequently reﬁned with supporting
exoglycosidase data, using the autoGU tool. Using data from
a series of exoglycosidases, autoGU creates a reﬁned list of
structural assignments that match the supporting digest foot-
print, i.e. observed shifts in GU values are due to the cleavage
of terminal monosaccharides whose identities depend on
enzyme speciﬁcity. GlycoBase in combination with autoGU
can be used to interpret and assign HPLC proﬁles; providing
an invaluable tool that is frequently used by international
biotechnology and pharmaceutical companies, as well as
academic institutions (Saldova et al. 2007; Abd Hamid et al.
Fig. 4. EUROCarbDB web portal. Screenshot demonstrates the information shown for each glycan structure within the database. Features of note include: links
to evidence, annotated biological contexts and references, control panel to change graphical representation of structures, automatic superstructure search and main
navigation bar.
Fig. 5. Relationships between analysis tools and the EUROCarbDB. The
ﬁgure represents the analytical workﬂows designed for EUROCarbDB,
speciﬁcally highlighting the central role of the developed tools.
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4992008; Royle et al. 2008; Liu et al. 2010; Marino et al. 2010;
Tharmalingam et al. 2010).
Glyco-Peakﬁnder. Glyco-Peakﬁnder (http://www.glyco-
peakﬁnder.org; Maass et al. 2007) is a web-based software tool
for semi-automatic de novo composition analysis of glycans,
providing computer assistance in the analysis of fragmentation
patterns and the laborious manual annotation of all kinds of
carbohydrate MS spectra. Thus, the software can be used for
the prediction and veriﬁcation of the annotations which can be
entered into EUROCarbDB, and workﬂows have been deﬁned
which integrate Glyco-Peakﬁnder into the input strategy for
MS evidence in EUROCarbDB. The software functionalities
are also available within GlycoWorkbench.
GlycoWorkbench. GlycoWorkbench (http://www.
glycoworkbench.org; Ceroni et al. 2008)i sas t a n d a l o n e
desktop application that provides a suite of tools for the routine
annotation and computer-assisted interpretation of glycan mass
spectra. A key feature is the semi-automated correlation of
observed fragment masses with computer-generated
fragmentation patterns on input structures proposed by the
researcher. The graphical interface provides an environment in
which structure models can be rapidly assembled using
GlycanBuilder, automatically matched with MS
n data and
compared with assess the best candidate. GlycoWorkbench
provides a fully integrated workﬂow to generate an annotated
list of peaks from an MS experiment and to upload the results
to the database. The software supports a wide variety of
structural constituents and annotation options, as well as an
exhaustive collection of fragmentation types.
Glyco-Peakﬁnder and GlycoWorkbench software tools have
been widely used for calculation of monosaccharide compo-
sitions, annotation of mass spectra and identiﬁcation of oligo-
saccharide fragments obtained by tandem MS. Examples are,
inter alia, the structural characterization of N-glycans from the
freshwater snail Biomphalaria glabrata (Lehr et al. 2007),
glycomic analyses of N- and O-linked carbohydrate epitopes
of the neural cell adhesion molecule CD24 from mouse brain
(Bleckmann, Geyer, Lieberoth, et al. 2009; Bleckmann,
Geyer, Reinhold, et al. 2009), the characterization of the
acidic N-glycans of the zona pellucida of prepuberal pigs (von
Witzendorff et al. 2009), glycomic analyses of human neutro-
phil N- and O-linked carbohydrate epitopes from Babu et al.
(2009), analysis of the human seminal plasma glycome (Pang
et al. 2009) and structural elucidation of glycosaminoglycans
(Tissot et al. 2008).
Computer-assisted spectrum evaluation of regular
polysaccharides
CASPER (http://www.casper.organ.su.se/eurocarbdb/casper.
action) is a software tool which uses empirical increment rules
based on experimental reference data to perform
1Ha n d
13C
NMR chemical shift prediction for oligo- and polysaccharides
(Jansson et al. 2006; Stenutz 2009). The reference database has
been derived from standardized measurements on a representa-
tive collection of mono-, di- and trisaccharides (substructures).
The data for the constituent monosaccharides comprising
any glycan are used to create a zero-order prediction set.
Differences between the observed chemical shifts for mono-
and disaccharides provide a set of ﬁrst-order chemical shift
increments (glycosylation shifts), whereas trisaccharides
provide additional second-order chemical shift corrections for
vicinal branch points. This means that CASPER can be used
both as a reference tool to retrieve chemical shifts of monosac-
charides as well as to calculate the chemical shifts of complex
oligo- and polysaccharides for comparison with experimental
data and thereby aid in structure assignment.
In a complementary manner, CASPER can be used for
glycan structure prediction on the basis of NMR data. As input
CASPER accepts uncorrelated
1Ha n d
13Cc h e m i c a ls h i f t s ,o r
correlated pairs of
13C/
1H chemical shifts (e.g. from 2D-NMR
experiments). In addition, information about coupling constants
at the anomeric centers (
3JHH and
1JCH)c a nb ee n t e r e dt ol i m i t
the number of possible structures and shorten the calculation
times. CASPER can deal with uncertain linkage positions and
unknown residue identities for cases where chemical analysis is
incomplete, but the calculations will require more time. First,
the software generates all possible structures consistent with
data provided by the user. The chemical shifts for each struc-
ture are then predicted as described above and compared with
the experimental chemical shifts of the unknown glycan. The
structures are ranked according to the quality of agreement
between observed and predicted chemical shifts. When necess-
ary, the user can then more efﬁciently plan additional experi-
ments for unambiguous structure conﬁrmation.
CASPER is also used directly by the EUROCarbDB to check
the consistency of new data during submission to the NMR
evidence database and can warn the user about possible mistakes
in NMR signal assignments (large deviations between observed
and predicted chemical shifts). CASPER can use CCPN projects
as data input and can also save results in that format.
ProSpectND. ProSpectND is an open-source, end-user
software for the processing and evaluation of one- and
multidimensional NMR data (http://sourceforge.net/projects/
prospectnd/). It runs natively on all major platforms (Unix/
X-windows, Microsoft Windows and Mac OSX). Through
versatile scripting tools, raw data from both Bruker and Varian
NMR spectrometers can be handled. ProSpectND provides
comprehensive features for the entire data processing
workﬂow. The optimally processed spectra can then be
transferred to the CCPN analysis tools for the signal
assignment phase. In addition, ProSpectND can be used to
carry out exact quantum-mechanical one-dimensional
1H-NMR spectrum simulations for deﬁned spin systems. Such
simulations, which include the second-order effects of strong
coupling, have been shown to be of great assistance in
conﬁrming the details of carbohydrate signal assignments,
especially in the case of overlapping multiplets. ProSpectND
is feature rich and open source, making it a good alternative
to commercial processing software.
Outlook
Recent experience clearly indicates that, following in the foot-
steps of genomics and proteomics, the next explosively devel-
oping ﬁelds in the biosciences will be glycomics and
C-W von der Lieth et al.
500metabolomics. The EUROCarbDB initiative has removed one
of the key stumbling blocks impeding progress in glycomics
by providing the glycobiology community with (i) universal
standards for the representation of monosaccharides and
complex glycans, (ii) a freely accessible database of known
glycan structures and experimental evidence, which embodies
these standards, (iii) freely accessible analytical tools for
carbohydrate researchers and (iv) a technical framework of
open-source code libraries and applications for carbohydrate
bioinformatics.
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